Russian draft law would abolish local clinical trial requirement
This article was originally published in SRA
Executive Summary
Pharmaceutical companies hoping for improvements in the Russian clinical trial environment will be encouraged by a provision in a recent draft law aimed at abolishing the requirement for foreign firms to carry out local trials when seeking a new drug approval1,2.